Embody vs TMates: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 3, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: TMates scores higher on our rubric, 7.8/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - from $69/mo →or find your match

TMates beats Embody overall, scoring 7.8/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; TMates is from $158/mo. Choose Embody for people comfortable committing to a term, since embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied. Choose TMates for users who want commitment-discount pricing on compounded glp-1s (semaglutide $158-$249/mo, tirzepatide $167-$297/mo, medication included) or a $99/mo clinical path to brand wegovy or zepbound filled at their own pharmacy.

A side-by-side look at Embody and TMates to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Embody

#28 of 54

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan.

Visit Embody

Higher Rated

TMates

#10 of 54

7.8/10

Telemedicine platform offering two distinct archetypes: compounded semaglutide and tirzepatide with medication included (semaglutide $158-$249/mo, tirzepatide $167-$297/mo on commitment pricing), and a clinical-service-only path to brand-name Wegovy/Zepbound at $99/mo where the prescription is sent to the patient's pharmacy. Phentermine also available. 2026 expansion added brand-name FDA-approved options.

Visit TMates

Feature	Embody	TMates
Why each one	Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied.	Two-archetype platform: (1) compounded GLP-1s with medication included and steep multi-month commitment discounts; (2) cheap $99/mo clinical service for brand Wegovy/Zepbound where you fill the prescription at your own pharmacy.
Our Score	7.3/10	7.8/10
Headline Price	from $69/mo	from $158/mo
Medication Type	Compounded	Both
Insurance Accepted	No	Yes
Best For	People comfortable committing to a term, since Embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied	Users who want commitment-discount pricing on compounded GLP-1s (semaglutide $158-$249/mo, tirzepatide $167-$297/mo, medication included) or a $99/mo clinical path to brand Wegovy or Zepbound filled at their own pharmacy
Watch out for	Everything you pay is non-refundable. Embody's refund policy, dated August 25, 2026, says all payments are final at the time of purchase, that cancelling stops future billing only, and that multi-month plans are non-refundable in whole and in part, so the twelve-month plan commits $828 up front and cancellations have to reach support at least 72 hours before the next billing date.	The $99/mo Wegovy or Zepbound tier buys the prescription and provider oversight only. TMates says it does not dispense or ship the drug, and no price for the medication itself appears on its product or category pages, so your own pharmacy bills you separately (checked 2026-09-03).
Ranking	#28	#10
Get started	Visit Embody	Visit TMates

Pros & Cons Compared

Embody

Pros

+Publishes a complete price ladder for both molecules, so what each advertised rate costs up front is checkable: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months.
+Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
+Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
+Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and the all-sales-final rule are readable before you pay.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Everything you pay is non-refundable. Embody's refund policy, dated August 25, 2026, says all payments are final at the time of purchase, that cancelling stops future billing only, and that multi-month plans are non-refundable in whole and in part, so the twelve-month plan commits $828 up front and cancellations have to reach support at least 72 hours before the next billing date.
−The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
−Trustpilot rating is 3.7 / 5 across 6,825 reviews, checked 2026-09-03, while the landing page advertises 4.8. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
−Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
−Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others, and SnagRx sells the same compounded semaglutide and tirzepatide at the same $69 and $119 prices Embody's own landing page shows. See our [SnagRx review](/reviews/snagrx)

TMates

Pros

+Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
+Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
+Same price at all dose levels for compounded, no cost escalation as you titrate up
+Phentermine available at $149/mo for patients who benefit from a different appetite-suppressant approach

Cons

−The $99/mo Wegovy or Zepbound tier buys the prescription and provider oversight only. TMates says it does not dispense or ship the drug, and no price for the medication itself appears on its product or category pages, so your own pharmacy bills you separately (checked 2026-09-03).
−The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
−The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.
−TMates prescribes brand-name but does not dispense it, and is not affiliated with Novo Nordisk (Wegovy) or Eli Lilly (Zepbound). Your own pharmacy fills the Rx.

Our Verdict

TMates edges out Embody with a score of 7.8/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; TMates is from $158/mo. TMates accepts insurance, which can significantly reduce your out-of-pocket costs. TMates offers both brand-name and compounded medications, giving you more flexibility.